| Year |
Citation |
Score |
| 2023 |
Tbeileh N, Timmerman L, Mattis AN, Toriguchi K, Kasai Y, Corvera C, Nakakura E, Hirose K, Donner DB, Warren RS, Karelehto E. Metastatic colorectal adenocarcinoma tumor purity assessment from whole exome sequencing data. Plos One. 18: e0271354. PMID 37022995 DOI: 10.1371/journal.pone.0271354 |
0.302 |
|
| 2020 |
Wisneski AD, Jin C, Huang CY, Warren R, Hirose K, Nakakura EK, Corvera CU. Synchronous Versus Metachronous Colorectal Liver Metastasis Yields Similar Survival in Modern Era. The Journal of Surgical Research. 256: 476-485. PMID 32798995 DOI: 10.1016/J.Jss.2020.06.038 |
0.328 |
|
| 2020 |
Kasai Y, Nakakura EK. Awareness of a mesenteric mass as a common manifestation of ileal neuroendocrine tumor. Surgical Case Reports. 6: 110. PMID 32448968 DOI: 10.1186/S40792-020-00875-0 |
0.402 |
|
| 2020 |
Zhang Z, Mäkinen N, Kasai Y, Kim GE, Diosdado B, Nakakura E, Meyerson M. Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors. Genes, Chromosomes & Cancer. PMID 32291827 DOI: 10.1002/Gcc.22850 |
0.36 |
|
| 2020 |
Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK. A novel stratification of mesenteric mass involvement as a predictor of challenging mesenteric lymph node dissection by minimally invasive approach for ileal neuroendocrine tumors. Journal of Surgical Oncology. PMID 32291778 DOI: 10.1002/Jso.25930 |
0.31 |
|
| 2020 |
Chen K, Whitman J, Paciorek A, Nakakura EK, Fidelman N, Feng MU, Bergsland EK, Anwar M. Outcomes after high-dose radiation in management of neuroendocrine neoplasms. Journal of Clinical Oncology. 38: 616-616. DOI: 10.1200/Jco.2020.38.4_Suppl.616 |
0.303 |
|
| 2020 |
Antonia RJ, Toriguchi K, Karelehto E, Annuar D, Timmerman L, Tbeileh N, Mattis AN, Corvera CU, Hirose K, Nakakura EK, Donner DB, Warren RS. Patient-derived organoids for personalized drug screening in intrahepatic cholangiocarcinoma. Journal of Clinical Oncology. 38: 581-581. DOI: 10.1200/Jco.2020.38.4_Suppl.581 |
0.306 |
|
| 2019 |
Kasai Y, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Harun N, Kim MO, Warren RS, Bergsland EK, Nakakura EK. Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis. Journal of Surgical Oncology. PMID 31828813 DOI: 10.1002/Jso.25811 |
0.371 |
|
| 2019 |
Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK. Prognostic impact of a large mesenteric mass >2 cm in ileal neuroendocrine tumors. Journal of Surgical Oncology. PMID 31613999 DOI: 10.1002/Jso.25727 |
0.369 |
|
| 2019 |
Kwon DH, Paciorek A, Mulvey CK, Chan H, Fidelman N, Meng L, Nakakura EK, Zhang L, Bergsland EK, Van Loon K. Periprocedural Management of Patients Undergoing Liver Resection or Embolotherapy for Neuroendocrine Tumor Metastases. Pancreas. PMID 30946246 DOI: 10.1097/Mpa.0000000000001271 |
0.382 |
|
| 2019 |
Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK, Fountzilas C, Wolpin BM, Al-Hawary M, Asbun H, Behrman SW, Benson AB, Binder E, Cardin DB, Cha C, ... ... Nakakura EK, et al. Pancreatic Adenocarcinoma, Version 1.2019. Journal of the National Comprehensive Cancer Network : Jnccn. 17: 202-210. PMID 30865919 DOI: 10.6004/Jnccn.2019.0014 |
0.312 |
|
| 2019 |
Donner DB, Ruan DT, Toriguchi K, Bergsland EK, Nakakura EK, Lin MH, Antonia RJ, Warren RS. Mitogen Inducible Gene-6 Is a Prognostic Marker for Patients with Colorectal Liver Metastases. Translational Oncology. 12: 550-560. PMID 30639964 DOI: 10.1016/J.Tranon.2018.12.007 |
0.306 |
|
| 2019 |
Esquivel M, Chee B, Shih B, Zhang L, Corvera CU, Hirose K, Nakakura EK, Van Loon K, Raymond VM, Dix D, Odegaard J, Atreya CE. Circulating tumor derived cell-free DNA (ctDNA) to predict recurrence of metastatic colorectal cancer (mCRC) following curative intent surgery or radiation: Interim results. Journal of Clinical Oncology. 37: 552-552. DOI: 10.1200/Jco.2019.37.4_Suppl.552 |
0.318 |
|
| 2019 |
Kasai Y, Mahuron KM, Hirose K, Corvera CU, Kim GE, Shih BE, Warren RS, Bergsland EK, Nakakura EK. Prognostic Impact of Desmoplastic Lymphadenopathy on Preoperative Imaging in Ileum Neuroendocrine Tumors Journal of the American College of Surgeons. 229: e54-e55. DOI: 10.1016/J.Jamcollsurg.2019.08.775 |
0.354 |
|
| 2018 |
Chamberlain CE, German MS, Yang K, Wang J, VanBrocklin H, Regan M, Shokat KM, Ducker GS, Kim GE, Hann B, Donner DB, Warren RS, Venook AP, Bergsland EK, Lee D, ... ... Nakakura EK, et al. A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-Resistant Tumors. Molecular Cancer Therapeutics. PMID 30254185 DOI: 10.1158/1535-7163.Mct-17-1204 |
0.38 |
|
| 2018 |
Kim SS, Ko AH, Nakakura EK, Wang ZJ, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Kim GE. Comparison of Tumor Regression Grading of Residual Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Chemotherapy Without Radiation: Would Fewer Tier-Stratification Be Favorable Toward Standardization? The American Journal of Surgical Pathology. PMID 30211728 DOI: 10.1097/Pas.0000000000001152 |
0.324 |
|
| 2017 |
Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW, Benson AB, Binder E, Cardin DB, Cha C, Chiorean EG, Chung V, Czito B, Dillhoff M, Dotan E, ... ... Nakakura EK, et al. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 15: 1028-1061. PMID 28784865 DOI: 10.6004/Jnccn.2017.0131 |
0.341 |
|
| 2017 |
Nakakura EK. Challenges Staging Neuroendocrine Tumors of the Pancreas, Jejunum and Ileum, and Appendix. Annals of Surgical Oncology. PMID 28779367 DOI: 10.1245/S10434-017-6026-9 |
0.365 |
|
| 2017 |
Greene C, Nakakura EK, Ko AH. Gastrocutaneous Fistula in a Patient with Locally Recurrent MSI-High Colorectal Cancer: Local Complications Arising from Therapeutic Response to Immune Checkpoint Blockade. Anticancer Research. 37: 3679-3684. PMID 28668860 DOI: 10.21873/Anticanres.11739 |
0.374 |
|
| 2017 |
Howe JR, Cardona K, Fraker DL, Kebebew E, Untch BR, Wang YZ, Law CH, Liu EH, Kim MK, Menda Y, Morse BG, Bergsland EK, Strosberg JR, Nakakura EK, Pommier RF. The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society. Pancreas. 46: 715-731. PMID 28609357 DOI: 10.1097/Mpa.0000000000000846 |
0.376 |
|
| 2017 |
Mulvey CK, Van Loon K, Bergsland EK, Masharani U, Nakakura EK. Complicated Case Presentation: Management of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1. Pancreas. 46: 416-426. PMID 28187108 DOI: 10.1097/Mpa.0000000000000770 |
0.383 |
|
| 2017 |
Kwon D, Mulvey C, Paciorek AT, Chan H, Meng L, Zhang L, Nakakura EK, Fidelman N, Bergsland EK, Van Loon K. Periprocedural management of patients undergoing liver resection or liver-directed therapy for neuroendocrine tumor metastases. Journal of Clinical Oncology. 35: e15689-e15689. DOI: 10.1200/Jco.2017.35.15_Suppl.E15689 |
0.35 |
|
| 2016 |
Kim SS, Nakakura EK, Wang ZJ, Kim GE, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Ko AH. Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy? Journal of Surgical Oncology. PMID 27444658 DOI: 10.1002/Jso.24375 |
0.32 |
|
| 2016 |
Nakakura EK. Finding the Common Thread in Rare Diseases. Jama Surgery. 151: 355. PMID 26630540 DOI: 10.1001/Jamasurg.2015.4215 |
0.349 |
|
| 2016 |
Ko AH, Cinar P, Tempero MA, Nakakura EK, Yeh BM, Chondros D. Perioperative stromal depletion by PEGPH20 in pancreatic ductal adenocarcinoma. Journal of Clinical Oncology. 34: TPS476-TPS476. DOI: 10.1200/Jco.2016.34.4_Suppl.Tps476 |
0.355 |
|
| 2016 |
Kim SS, Nakakura EK, Wang ZJ, Kim GE, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Ko AH. Is neoadjuvant chemoradiation important in borderline resectable pancreatic cancer (BRPC)? Clinical and surgical outcomes associated with preoperative FOLFIRINOX alone in BRPC. Journal of Clinical Oncology. 34: 351-351. DOI: 10.1200/Jco.2016.34.4_Suppl.351 |
0.306 |
|
| 2015 |
Van Loon K, Zhang L, Creasman JM, Choti MA, Yao JC, Kulke MH, Nakakura EK, Bloomston M, Benson AB, Shah MH, Strosberg JR, Zornosa CC, Bobiak S, Bergsland EK. Recurrence following surgical resection of gastroenteropancreatic neuroendocrine tumors (NETs): An analysis from the NCCN oncology outcomes database. Journal of Clinical Oncology. 33: 4107-4107. DOI: 10.1200/Jco.2015.33.15_Suppl.4107 |
0.398 |
|
| 2014 |
Tempero MA, Malafa MP, Behrman SW, Benson AB, Casper ES, Chiorean EG, Chung V, Cohen SJ, Czito B, Engebretson A, Feng M, Hawkins WG, Herman J, Hoffman JP, Ko A, ... ... Nakakura EK, et al. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. Journal of the National Comprehensive Cancer Network : Jnccn. 12: 1083-93. PMID 25099441 DOI: 10.6004/Jnccn.2014.0106 |
0.311 |
|
| 2014 |
Bergsland EK, Nakakura EK. Neuroendocrine tumors of unknown primary: is the primary site really not known? Jama Surgery. 149: 889-90. PMID 25029597 DOI: 10.1001/Jamasurg.2014.216 |
0.347 |
|
| 2013 |
Wang SC, Fidelman N, Nakakura EK. Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver. Seminars in Oncology. 40: 69-74. PMID 23391114 DOI: 10.1053/J.Seminoncol.2012.11.007 |
0.374 |
|
| 2013 |
Choti MA, Bobiak S, Bloomston M, Zornosa CC, Bergsland EK, Strosberg JR, Benson AB, Kulke M, Shah MH, Nakakura EK, Yao JC. Treatment of liver metastases in patients with neuroendocrine tumors: A National Comprehensive Cancer Network analysis. Journal of Clinical Oncology. 31: 4143-4143. DOI: 10.1200/Jco.2013.31.15_Suppl.4143 |
0.399 |
|
| 2012 |
Choti MA, Mayorga MA, Bobiak S, Kulke M, Yao JC, Bergsland EK, Nakakura EK, Bloomston M, Benson AB, Shah MH, Strosberg JR. Baseline demographics of patients with neuroendocrine tumors presenting to seven National Comprehensive Cancer Network (NCCN) institutions: Development of a multi-institutional outcomes database. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 187. PMID 27983443 DOI: 10.1200/Jco.2012.30.4_Suppl.187 |
0.357 |
|
| 2012 |
Keiser J, Nakakura EK, Imhoff L, Mayorga MA, Bobiak S, Venook AP, Bergsland EK. Incidence and natural history of bone metastases in neuroendocrine tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 340. PMID 27983077 DOI: 10.1200/Jco.2012.30.4_Suppl.340 |
0.359 |
|
| 2012 |
Bergsland EK, Watt L, Ko AH, Tempero MA, Korn WM, Kelley RK, Weber T, Siah I, Hwang J, Nakakura EK, Venook AP. A phase II study to evaluate the safety and efficacy of RAD001 plus erlotinib in patients with well-differentiated neuroendocrine tumors (NET). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 285. PMID 27982815 DOI: 10.1200/Jco.2012.30.4_Suppl.285 |
0.321 |
|
| 2012 |
Parekh JR, Wang SC, Bergsland EK, Venook AP, Warren RS, Kim GE, Nakakura EK. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients. Pancreas. 41: 840-4. PMID 22781907 DOI: 10.1097/Mpa.0B013E31823Cdaa0 |
0.392 |
|
| 2012 |
Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB, Casper ES, Cohen SJ, Czito B, Ellenhorn JD, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, ... ... Nakakura EK, et al. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network : Jnccn. 10: 703-13. PMID 22679115 DOI: 10.6004/Jnccn.2012.0073 |
0.33 |
|
| 2012 |
Nakakura EK. Pseudomyxoma peritonei: more questions than answers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 2429-30. PMID 22614983 DOI: 10.1200/Jco.2012.42.3764 |
0.384 |
|
| 2012 |
Zornosa CC, Choti MA, Bobiak S, Kulke M, Yao JC, Bergsland EK, Nakakura EK, Bloomston M, Benson AB, Shah MH, Strosberg JR. Baseline demographics of neuroendocrine tumor patients presenting to seven National Comprehensive Cancer Network (NCCN) institutions: Development of a multi-institutional outcomes database. Journal of Clinical Oncology. 30: e14551-e14551. DOI: 10.1200/Jco.2012.30.15_Suppl.E14551 |
0.379 |
|
| 2012 |
Choti MA, Bobiak S, Strosberg JR, Benson AB, Bloomston M, Yao JC, Zornosa CC, Bergsland EK, Kulke M, Nakakura EK, Shah MH. Prevalence of functional tumors in neuroendocrine carcinoma: An analysis from the NCCN NET database. Journal of Clinical Oncology. 30: 4126-4126. DOI: 10.1200/Jco.2012.30.15_Suppl.4126 |
0.306 |
|
| 2012 |
Imhoff L, Keiser J, Bergsland E, Nakakura E. Aggressive Surgical Management Best Serves Patients With Small Intestinal Neuroendocrine Tumors Journal of Surgical Research. 172: 195. DOI: 10.1016/J.Jss.2011.11.159 |
0.387 |
|
| 2011 |
Tseng WW, Wang SC, Eichler CM, Warren RS, Nakakura EK. Complete and safe resection of challenging retroperitoneal tumors: anticipation of multi-organ and major vascular resection and use of adjunct procedures. World Journal of Surgical Oncology. 9: 143. PMID 22054416 DOI: 10.1186/1477-7819-9-143 |
0.395 |
|
| 2011 |
Wang Y, Donner D, Venook A, Bergsland E, Warren R, Nakakura E. A Primary Xenograft Model of Pancreatic Neuroendocrine Carcinoma Maintains a Neuroendocrine Tumor Gene Expression Signature Journal of Surgical Research. 165: 296. DOI: 10.1016/J.Jss.2010.11.379 |
0.389 |
|
| 2010 |
Wang YC, Iezza G, Zuraek MB, Jablons DM, Theodore PR, Bergsland EK, Donner DB, Warren RS, Nakakura EK. Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary site. The Journal of Surgical Research. 163: 47-51. PMID 20599218 DOI: 10.1016/J.Jss.2010.04.018 |
0.406 |
|
| 2010 |
Wang SC, Parekh JR, Zuraek MB, Venook AP, Bergsland EK, Warren RS, Nakakura EK. Identification of unknown primary tumors in patients with neuroendocrine liver metastases. Archives of Surgery (Chicago, Ill. : 1960). 145: 276-80. PMID 20231629 DOI: 10.1001/Archsurg.2010.10 |
0.419 |
|
| 2010 |
Wang YC, Zuraek MB, Kosaka Y, Ota Y, German MS, Deneris ES, Bergsland EK, Donner DB, Warren RS, Nakakura EK. The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine. Endocrine-Related Cancer. 17: 283-91. PMID 20048018 DOI: 10.1677/Erc-09-0243 |
0.346 |
|
| 2010 |
Nakakura E, Wong M, Wang Y, Iezza G, Zuraek M, Yuan X, Donner D, Hanahan D, Warren R, Bergsland E. Distinct mTOR Pathway Activity in Neuroendocrine Tumors of the Pancreas and Small Intestine Revealed by Immunohistochemical Analysis Pancreas. 39: 276. DOI: 10.1097/01.Mpa.0000363927.24091.1C |
0.375 |
|
| 2010 |
Nakakura E, Iezza G, Zuraek M, Jablons D, Theodore P, Donner D, Bergsland E, Warren R, Wang Y. Lack of NKX2.2 Transcription Factor Expression Distinguishes Bronchopulmonary Typical Carcinoids from Gastrointestinal Neuroendocrine Tumors Journal of Surgical Research. 158: 267. DOI: 10.1016/J.Jss.2009.11.270 |
0.4 |
|
| 2010 |
Nakakura E, Zuraek M, Donner D, Bergsland E, Warren R, Wang Y. Reduced GFI1 Transcription Factor Expression in Small Intestinal Neuroendocrine Tumor Metastases Journal of Surgical Research. 158: 266-267. DOI: 10.1016/J.Jss.2009.11.269 |
0.402 |
|
| 2009 |
Olson P, Lu J, Zhang H, Shai A, Chun MG, Wang Y, Libutti SK, Nakakura EK, Golub TR, Hanahan D. MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes & Development. 23: 2152-65. PMID 19759263 DOI: 10.1101/Gad.1820109 |
0.313 |
|
| 2009 |
Wang YC, Gallego-Arteche E, Iezza G, Yuan X, Matli MR, Choo SP, Zuraek MB, Gogia R, Lynn FC, German MS, Bergsland EK, Donner DB, Warren RS, Nakakura EK. Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors. Endocrine-Related Cancer. 16: 267-79. PMID 18987169 DOI: 10.1677/Erc-08-0127 |
0.398 |
|
| 2009 |
Wang Y, Zuraek M, Donner D, Bergsland E, Warren R, Nakakura E. QS138. The FEV Transcription Factor is Abberantly Expressed in Neuroendocrine Tumors of the Small Intestine Journal of Surgical Research. 151: 288. DOI: 10.1016/J.Jss.2008.11.435 |
0.39 |
|
| 2008 |
Ruan DT, Warren RS, Moalem J, Chung KW, Griffin AC, Shen W, Duh QY, Nakakura E, Donner DB, Khanafshar E, Weng J, Clark OH, Kebebew E. Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid cancers. Surgery. 144: 908-13; discussion 9. PMID 19040996 DOI: 10.1016/J.Surg.2008.07.028 |
0.308 |
|
| 2007 |
Nakakura EK, Warren RS. Palliative care for patients with advanced pancreatic and biliary cancers. Surgical Oncology. 16: 293-7. PMID 17855076 DOI: 10.1016/J.Suronc.2007.08.003 |
0.308 |
|
| 2007 |
Nakakura EK, Venook AP, Bergsland EK. Systemic and regional nonsurgical therapy--what is the optimal strategy for metastatic neuroendocrine cancer? Surgical Oncology Clinics of North America. 16: 639-51, x. PMID 17606198 DOI: 10.1016/J.Soc.2007.04.019 |
0.337 |
|
| 2007 |
Nakakura EK, Bergsland EK. Islet cell carcinoma: neuroendocrine tumors of the pancreas and periampullary region. Hematology/Oncology Clinics of North America. 21: 457-73; viii. PMID 17548034 DOI: 10.1016/J.Hoc.2007.04.005 |
0.415 |
|
| 2007 |
Nakakura EK, Gallego E, Lynn F, German M, Wang Y. Nkx2.2 homeodomain transcription factor is required for the development of serotonin-producing cells in the gut Journal of the American College of Surgeons. 205: S18. DOI: 10.1016/J.Jamcollsurg.2007.06.036 |
0.304 |
|
| 2006 |
Nakakura E, Ball D. The Notch signaling effector Hes1 in gastrointestinal carcinoid tumor cells oncology Journal of Surgical Research. 130: 265. DOI: 10.1016/J.Jss.2005.11.297 |
0.39 |
|
| 2005 |
Nakakura EK, Sriuranpong VR, Kunnimalaiyaan M, Hsiao EC, Schuebel KE, Borges MW, Jin N, Collins BJ, Nelkin BD, Chen H, Ball DW. Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling. The Journal of Clinical Endocrinology and Metabolism. 90: 4350-6. PMID 15870121 DOI: 10.1210/Jc.2005-0540 |
0.624 |
|
| 2002 |
Sriuranpong V, Borges MW, Strock CL, Nakakura EK, Watkins DN, Blaumueller CM, Nelkin BD, Ball DW. Notch signaling induces rapid degradation of achaete-scute homolog 1. Molecular and Cellular Biology. 22: 3129-39. PMID 11940670 DOI: 10.1128/Mcb.22.9.3129-3139.2002 |
0.57 |
|
| 2001 |
Nakakura EK, Watkins DN, Sriuranpong V, Borges MW, Nelkin BD, Ball DW. Mammalian Scratch participates in neuronal differentiation in P19 embryonal carcinoma cells. Brain Research. Molecular Brain Research. 95: 162-6. PMID 11687288 DOI: 10.1016/S0169-328X(01)00246-7 |
0.555 |
|
| 2001 |
Nakakura EK, Watkins DN, Schuebel KE, Sriuranpong V, Borges MW, Nelkin BD, Ball DW. Mammalian Scratch: a neural-specific Snail family transcriptional repressor. Proceedings of the National Academy of Sciences of the United States of America. 98: 4010-5. PMID 11274425 DOI: 10.1073/Pnas.051014098 |
0.559 |
|
| 2001 |
Nakakura EK, Sriuranpong V, Borges MW, Watkins N, Nelkin BD, Ball DW, Chen H. Regulation of the neuroendocrine phenotype in pancreatic carcinoid tumor cells Gastroenterology. 120: A349. DOI: 10.1016/S0016-5085(08)81734-9 |
0.62 |
|
| Show low-probability matches. |